The role of radiotherapy in multimodal treatment of pancreatic carcinoma.

Pancreatic ductal carcinoma is one of the most lethal malignancies, but in recent years a number of positive developments have occurred in the management of pancreatic carcinoma. This article aims to give an overview of the current knowledge regarding the role of radiotherapy in the treatment of pan...

Full description

Bibliographic Details
Main Authors: Brunner, T, Scott-Brown, M
Format: Journal article
Language:English
Published: 2010
_version_ 1826260920694734848
author Brunner, T
Scott-Brown, M
author_facet Brunner, T
Scott-Brown, M
author_sort Brunner, T
collection OXFORD
description Pancreatic ductal carcinoma is one of the most lethal malignancies, but in recent years a number of positive developments have occurred in the management of pancreatic carcinoma. This article aims to give an overview of the current knowledge regarding the role of radiotherapy in the treatment of pancreatic ductal adenocarcinoma (PDAC). The results of meta-analyses, phase III-studies, and phase II-studies using chemoradiotherapy and chemotherapy for resectable and non-resectable PDAC were reviewed. The use of radiotherapy is discussed in the neoadjuvant and adjuvant settings as well as in the locally advanced situation. Whenever possible, radiotherapy should be performed as simultaneous chemoradiotherapy. Patients with PDAC should be offered entry into clinical trials to identify optimal treatment results.
first_indexed 2024-03-06T19:13:23Z
format Journal article
id oxford-uuid:178a318c-a8d4-46e4-8ac3-d95aa9613809
institution University of Oxford
language English
last_indexed 2024-03-06T19:13:23Z
publishDate 2010
record_format dspace
spelling oxford-uuid:178a318c-a8d4-46e4-8ac3-d95aa96138092022-03-26T10:37:51ZThe role of radiotherapy in multimodal treatment of pancreatic carcinoma.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:178a318c-a8d4-46e4-8ac3-d95aa9613809EnglishSymplectic Elements at Oxford2010Brunner, TScott-Brown, MPancreatic ductal carcinoma is one of the most lethal malignancies, but in recent years a number of positive developments have occurred in the management of pancreatic carcinoma. This article aims to give an overview of the current knowledge regarding the role of radiotherapy in the treatment of pancreatic ductal adenocarcinoma (PDAC). The results of meta-analyses, phase III-studies, and phase II-studies using chemoradiotherapy and chemotherapy for resectable and non-resectable PDAC were reviewed. The use of radiotherapy is discussed in the neoadjuvant and adjuvant settings as well as in the locally advanced situation. Whenever possible, radiotherapy should be performed as simultaneous chemoradiotherapy. Patients with PDAC should be offered entry into clinical trials to identify optimal treatment results.
spellingShingle Brunner, T
Scott-Brown, M
The role of radiotherapy in multimodal treatment of pancreatic carcinoma.
title The role of radiotherapy in multimodal treatment of pancreatic carcinoma.
title_full The role of radiotherapy in multimodal treatment of pancreatic carcinoma.
title_fullStr The role of radiotherapy in multimodal treatment of pancreatic carcinoma.
title_full_unstemmed The role of radiotherapy in multimodal treatment of pancreatic carcinoma.
title_short The role of radiotherapy in multimodal treatment of pancreatic carcinoma.
title_sort role of radiotherapy in multimodal treatment of pancreatic carcinoma
work_keys_str_mv AT brunnert theroleofradiotherapyinmultimodaltreatmentofpancreaticcarcinoma
AT scottbrownm theroleofradiotherapyinmultimodaltreatmentofpancreaticcarcinoma
AT brunnert roleofradiotherapyinmultimodaltreatmentofpancreaticcarcinoma
AT scottbrownm roleofradiotherapyinmultimodaltreatmentofpancreaticcarcinoma